Startup brief
Defense Scale-Ups and FinTech Giants Power Israeli Tech Rebound
Late-stage scale-ups land Wall Street mega-rounds and establish European factories as Israeli tech raises $11B in nine months.
Startup
Wall Street consortiums injected $220M into Capitolis at a $1.9B valuation — consolidating global securities lending onto Tel Aviv financial infrastructure.
BackgroundCapitolis was established by Israeli entrepreneur Gil Mandelzis to automate capital marketplace compliance and compress bank balance sheets through algorithmic netting. Rising regulatory capital requirements have forced Wall Street lenders to shrink gross exposures without sacrificing trading client fees.
- The package combines $120M in Series E equity alongside a $100M debt facility provided by First Citizens Innovation Banking and Hercules Capital.
- A banking consortium including Bank of America, Nomura, Tradeweb, Barclays, and J.P. Morgan backed the valuation despite broader fintech valuation pullbacks.
- Acquiring eSecLending moves institutional securities lending directly into Capitolis's Tel Aviv software stack, creating recurring revenue across global trading desks.
Startup
Israeli startups raised $11B in nine months to surpass full-year 2025 — late-stage cyber and AI mega-rounds have fully broken the wartime venture drought.
BackgroundVenture funding in Israeli technology slumped during 2023 and 2024 amid rising interest rates and domestic wartime operational disruptions. Surging global demand for cybersecurity and enterprise AI infrastructure has since reignited late-stage mega-rounds across Tel Aviv.
- Data compiled by IVC Research and LeumiTech confirmed that 2026 high-tech funding through September officially surpassed the $10.7B raised throughout all of 2025.
- Capital remained concentrated in late-stage cybersecurity and autonomous enterprise software, headlined by private mega-rounds from scale-ups Island and Cyera.
- Foreign venture funds accounted for the majority of late-stage growth capital, counteracting early-stage seed funding softness across local accelerators.
Startup
Covenant built a sovereign arms plant in Germany — proving Israeli defense scale-ups can win NATO contracts by manufacturing directly on European soil.
BackgroundEuropean defense procurement rules mandate continental production to ensure national self-reliance during regional military conflicts. Tel Aviv founders Michael Kaufman and Ofir Dayan started Covenant with over $250M from Silicon Valley and Israeli venture funds.
- The Leipzig plant scales industrial assembly of long-range precision strike systems for European militaries seeking sovereign weapons supplies without foreign dependencies.
- Engineering Anthem hardware with less than 5% non-European components protects Covenant from third-party export vetoes during geopolitical disputes.
- The expansion demonstrates how top-tier Israeli defense founders are embedding physical manufacturing inside NATO territory to unlock massive continental rearmament contracts.
Startup
QuantHealth raised $45M from Qumra and Sanofi — proving pharmaceutical developers will pay to simulate patient trial outcomes before enrolling humans.
BackgroundDeveloping experimental biopharmaceuticals carries an 88% clinical trial failure rate that costs drug developers billions of dollars per candidate. Simulation algorithms model human pharmacological responses to forecast drug efficacy before physical patient trials ever begin.
- Participating venture backers include Pitango HealthTech, Bertelsmann Healthcare Investments, and Artofin Venture Capital, reinforcing institutional backing for computational biology.
- QuantHealth formed a commercial partnership with cell therapy firm GC Cell to design clinical trial protocols for its GCC2005 oncology drug candidate.
- The growth round shows biopharma sponsors are treating digital trial simulation as an essential cost-reduction tool rather than an experimental research technique.
Startup
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
